Spotlight
Twitter feed
Current and future progress to overcoming targeted drug resistance for #GastrointestinalCancers https://t.co/X8OXhLOpgp #ASCOEdBook #GICSM #GI21
Dr. Laurie Glimcher (@LGlimcherMD) spoke with @GreaterBoston's @jimbraude about the importance of cancer patients receiving the #COVID19 vaccine. Patients, survivors & family, remember to tune in today at 5 pm EST for a virtual discussion on the #vaccine
Dana-Farber CEO Highlights Importance Of Vaccinating Cancer Patients Against COVID-19
Doctor Laurie Glimcher, CEO of the Dana-Farber Cancer Institute, joined Jim Braude to discuss the importance ensuring vaccinations for a particularly ...
ms.spr.ly
Sonia Rocha @srochaliv @LivUni, @MKoritzinsky @PMResearch_UHN, and Paul Boutros @TheBoutrosLab @UCLA will discuss Hypoxia in a plenary session at the AACR virtual conference on Radiation Science and Medicine, March 2-3.
Learn more:
https://t.co/aqlKyDqWfR
#AACRrsm21
Continuity of Cancer Care in #COVID19:
@peters_solange, @TMWiseDraper, @SheenaBhallaMD, @ZhuoerXie, Karely Mann @huntsmancancer, and Giuseppe Curigliano @curijoey will address this topic at the #AACRCovid and Cancer virtual conference, Feb 3-5:
https://t.co/Ok54m7Ch8e
OPERA trial: Most patients with cT2, cT3a, or cT3b rectal cancer who develop a CR to treatment can forego surgery after neoadjuvant CRT plus an additional radiotherapy boost w/out compromising chance of cure #GI21 #ASCODailyNews
Organ Preservation Possible for Most Patients With Early or Locally Advanced Rectal Cancer
An early look at the data from the phase III OPERA (Organ Preservation in Early Rectal Adenocarcinoma) trial suggests that most patients with cT2, cT3...
fal.cn
“Due to the pandemic, there is a much greater appreciation of the immune system among the general public.”
Marcela Maus, MD, PhD @harvardmed discussed some of the challenges and opportunities in immunotherapy in 2021. #AACRBlog
https://t.co/yuTE81XTsv
New research from Dana-Farber/Brigham and Women's Cancer Center shows a drop in #cancer screenings at the start of the #COVID19 pandemic. Quoc-Dien Trinh, MD (@QDTrinh), details the study: https://t.co/gaUCgWS7mg cc @NBCNews. @BrighamWomens
AACR Affiliate-Advocate membership is open to survivors and advocates from organizations whose mission includes the advancement of cancer research. Member benefits include free registration to #AACR21 and 2021 Special Conferences. Learn more:
https://t.co/xz1r6JQlsh
Neoadjuvant #chemotherapy alters the immune microenvironment within PDAC, & different #chemo regimens exert different effects. This data may help determine how best to utilize chemotherapy in PDAC to maximize efficacy #GI21 #ASCODailyNews
Analysis of the PDAC Immune Microenvironment Sheds Light on the Effects of Chemotherapy, Informing Future Treatment Strategies
An exploratory study reveals that neoadjuvant chemotherapy alters the immune microenvironment within pancreatic ductal adenocarcinoma (PDAC), and diff...
fal.cn
Dana-Farber to host a virtual discussion for cancer patients and survivors about the #COVID19 vaccine: https://t.co/JANtibhgOH
Join us on Wednesday, January 27th at 5:00 pm EST ⬇💉
Announcements
Donor highlight
Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the development of revolutionary therapies to treat cancer. We are grateful for their vision and incredible support.
